LEVOCARNITINE

N/A

Manufactured by Leadiant Biosciences, Inc.

6,090 FDA adverse event reports analyzed

Last updated: 2026-04-15

About LEVOCARNITINE

LEVOCARNITINE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Leadiant Biosciences, Inc.. The most commonly reported adverse reactions for LEVOCARNITINE include SEIZURE, OFF LABEL USE, VOMITING, DIARRHOEA, DRUG INEFFECTIVE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for LEVOCARNITINE.

Top Adverse Reactions

SEIZURE361 reports
OFF LABEL USE254 reports
VOMITING216 reports
DIARRHOEA196 reports
DRUG INEFFECTIVE183 reports
FATIGUE172 reports
PNEUMONIA168 reports
PYREXIA163 reports
NAUSEA127 reports
PRODUCT DOSE OMISSION ISSUE125 reports
DECREASED APPETITE109 reports
DEATH108 reports
SOMNOLENCE108 reports
DYSPNOEA102 reports
HEADACHE82 reports
CONDITION AGGRAVATED80 reports
WEIGHT DECREASED79 reports
PRODUCT USE IN UNAPPROVED INDICATION77 reports
HOSPITALISATION75 reports
COVID 1974 reports
COUGH73 reports
CONSTIPATION72 reports
FALL72 reports
DEHYDRATION63 reports
DIZZINESS63 reports
INSOMNIA62 reports
RASH62 reports
ASTHENIA61 reports
URINARY TRACT INFECTION61 reports
ABDOMINAL PAIN60 reports
EPILEPSY58 reports
NASOPHARYNGITIS58 reports
HYPERAMMONAEMIA57 reports
INFLUENZA56 reports
WEIGHT INCREASED56 reports
OVERDOSE55 reports
RESPIRATORY FAILURE55 reports
SEPSIS51 reports
INFECTION49 reports
PAIN49 reports
HYPOTENSION48 reports
TREMOR47 reports
ANAEMIA45 reports
MALAISE44 reports
ABDOMINAL PAIN UPPER43 reports
STATUS EPILEPTICUS43 reports
GAIT DISTURBANCE41 reports
ANXIETY40 reports
DRUG INTERACTION40 reports
FEBRILE NEUTROPENIA40 reports
ILLNESS40 reports
PLATELET COUNT DECREASED39 reports
METABOLIC ACIDOSIS38 reports
PRODUCT USE ISSUE38 reports
PRURITUS38 reports
AMMONIA INCREASED37 reports
CARDIAC ARREST37 reports
CONVULSION37 reports
OEDEMA PERIPHERAL37 reports
SINUSITIS37 reports
ABDOMINAL DISCOMFORT36 reports
LETHARGY36 reports
UNDERDOSE36 reports
AGITATION35 reports
MUSCULAR WEAKNESS35 reports
WHITE BLOOD CELL COUNT DECREASED35 reports
ABDOMINAL DISTENSION34 reports
RENAL FAILURE34 reports
THROMBOCYTOPENIA34 reports
ARTHRALGIA33 reports
PANCREATITIS33 reports
PNEUMONIA ASPIRATION33 reports
GENERALISED TONIC CLONIC SEIZURE32 reports
HAEMOGLOBIN DECREASED32 reports
MUSCLE SPASMS32 reports
RHABDOMYOLYSIS32 reports
TOXICITY TO VARIOUS AGENTS32 reports
FEELING ABNORMAL31 reports
IRRITABILITY31 reports
PAIN IN EXTREMITY31 reports
RHINOVIRUS INFECTION31 reports
TACHYCARDIA31 reports
VIRAL INFECTION30 reports
ABNORMAL BEHAVIOUR29 reports
AGGRESSION29 reports
CARDIAC FAILURE29 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION29 reports
NEUROPATHY PERIPHERAL29 reports
ALANINE AMINOTRANSFERASE INCREASED28 reports
BLOOD PRESSURE INCREASED28 reports
HYPERTENSION28 reports
PRESCRIBED UNDERDOSE28 reports
DEVICE RELATED INFECTION27 reports
MULTIPLE ORGAN DYSFUNCTION SYNDROME27 reports
PANCYTOPENIA27 reports
PARAESTHESIA27 reports
PRODUCT PREPARATION ISSUE27 reports
GASTROENTERITIS VIRAL26 reports
SEPTIC SHOCK26 reports
TACHYPNOEA26 reports

Report Outcomes

Out of 3,426 classified reports for LEVOCARNITINE:

Serious 77.2%Non-Serious 22.8%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male1,461 (51.0%)
Female1,397 (48.8%)
Unknown4 (0.1%)

Reports by Age

Age 387 reports
Age 685 reports
Age 870 reports
Age 466 reports
Age 1162 reports
Age 1661 reports
Age 754 reports
Age 1853 reports
Age 252 reports
Age 552 reports
Age 149 reports
Age 1048 reports
Age 1448 reports
Age 945 reports
Age 1545 reports
Age 1744 reports
Age 1338 reports
Age 1237 reports
Age 2134 reports
Age 6333 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with LEVOCARNITINE?

This profile reflects 6,090 FDA FAERS reports that mention LEVOCARNITINE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for LEVOCARNITINE?

Frequently reported terms in FAERS include SEIZURE, OFF LABEL USE, VOMITING, DIARRHOEA, DRUG INEFFECTIVE, FATIGUE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures LEVOCARNITINE?

Labeling and FAERS entries often list Leadiant Biosciences, Inc. in connection with LEVOCARNITINE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.